News: Jubilant Life Sciences Ltd (JULS.BO)

JULS.BO on Bombay Stock Exchange

171.00INR
17 Apr 2014
Price Change (% chg)

Rs-0.30 (-0.18%)
Prev Close
Rs171.30
Open
Rs172.00
Day's High
Rs173.40
Day's Low
Rs168.00
Volume
32,480
Avg. Vol
58,017
52-wk High
Rs186.80
52-wk Low
Rs65.10

Search Stocks
Select another date:

Fri, Feb 28 2014

Jubilant Life up on resolution of FDA concerns on Canada facility

Reuters Market Eye - Shares in Jubilant Life Sciences gain 7.2 percent after the U.S. Food and Drug Administration (FDA) gives a green-light to its pharmaceutical manufacturing facility at Montreal, Canada.

MARKET EYE -Jubilant Life up on resolution of FDA concerns on Canada facility

* Shares in India's Jubilant Life Sciences gain 7.2 percent after the U.S. Food and Drug Administration (FDA) gives a green-light to its pharmaceutical manufacturing facility at Montreal, Canada. * "This resolves all issues raised by the FDA on the facility in February 2013 and subsequent communications," the company's statement added. * The company on Feb. 27 said U.S. health regulators issued a warning letter to the company, citing "significant violations" of manufacturing standards at its fa

Indian shares hit one-month closing high; exit polls see BJP ahead

* BSE index gains 1.2 pct; NSE ends 1.3 pct higher * Adani Group stocks surge * Jubilant shares plunge after FDA warning over U.S. plant By Abhishek Vishnoi MUMBAI, Dec 5 - Indian shares rose more than 1 percent on Thursday to their highest close in a month as stocks of blue chip companies such as ICICI Bank surged after exit polls predicted a strong showing for the key opposition party in state elections held recently. Confirmation of the exit poll predictions of

Jubilant Life plunges 10 percent after FDA warning for U.S. plant

MUMBAI - Drugmaker Jubilant Life Sciences Ltd said on Thursday it had received a warning from the U.S. Food and Drug Administration over manufacturing practices at one of its U.S. facilities, sending its shares the limit-down 10 percent.

India's Jubilant shares plunge after FDA warning for U.S. plant

MUMBAI, Dec 5 - Indian drugmaker Jubilant Life Sciences Ltd said on Thursday it had received a warning from the U.S. Food and Drug Administration over manufacturing practices at one of its U.S. facilities, sending its shares the limit-down 10 percent.

Indian shares gain nearly 1.5 pct; state election results key

* BSE index gains 1.25 pct; NSE ends 1.38 pct higher * Indian shares mark biggest weekly gain since Oct 11 * Jubilant Life surges after approval for key drug * India's small stocks outperform index; analysts wary By Abhishek Vishnoi MUMBAI, Nov 29 - Indian shares rose nearly 1.5 percent on Friday as hopes that domestic institutional investors would turn buyers sparked a rally in blue-chips such as ICICI Bank, allowing indexes to post their best weekly gain in nearl

Jubilant Life surges after approval for key drug

Reuters Market Eye - Shares in Jubilant Life Sciences surge 7.5 percent after the company said it got approval from the U.S. drug regulators for a generic version of AstraZeneca Plc's Seroquel drug, used for the treatment of schizophrenia and bipolar disorder.

MARKET EYE-India's Jubilant Life surges after approval for key drug

* Shares in India's Jubilant Life Sciences Ltd surge 7.5 percent after the company said it got approval from the U.S. drug regulators for a generic version of AstraZeneca Plc's Seroquel drug, used for the treatment of schizophrenia and bipolar disorder. * The company says the current total market size for the drug is $59 million per year, citing estimates by healthcare information provider IMS Health, and says it expects to launch this product in the fourth quarter of fiscal 2013/14. (abhish

Select another date:
Search Stocks